Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Electrosurgery or laser for benign prostatic enlargement: trumpcard or pitfalls47
Long-term outcome of urethral and genital reconstruction in hypospadias and exstrophy-epispadias complex34
Editorial introductions27
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments24
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies21
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects20
Research frontiers in urology19
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update18
The adverse impact of COVID-19 on men's health17
Editorial: Medical, technical and functional aspect of various types of urinary diversion17
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis17
The role of innovations in advancing urologic oncologic patient care17
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma16
Best nonsurgical managements of acute urinary retention: what's new?16
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker16
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations15
Editorial introductions14
Editorial introductions14
Sustainable practices in hospital and operating theaters14
Testicular cancer with small metastatic burden: optimal approach in 202414
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma14
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder13
RNA-based urinary assays for non-muscle invasive bladder cancer13
Editorial introductions13
Acute kidney injury in COVID-19: are kidneys the target or just collateral damage? A comprehensive assessment of viral RNA and AKI rate in patients with COVID-1912
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature12
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?12
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty11
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects10
Update on classification of oncocytic neoplasms of the kidney10
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints10
Is there a role for metastasis-directed therapy in bladder cancer?10
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature9
Applications of artificial intelligence in prostate cancer imaging9
Metabolic syndrome, obesity and cancer risk9
Preoperative geriatric assessment of urological patients: a narrative review8
Artificial intelligence in stone disease8
State of the art on stress incontinence management after benign prostatic obstruction surgery8
Decoding germ cell tumours for clinicians8
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities8
Management of vaginoplasty canal complications8
Preoperative patient optimization for endourological procedures: the current best clinical practice8
Brief update of the new WHO classification for urothelial carcinoma8
Minimally invasive surgery for benign prostatic obstruction: new insights and future technical standards8
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies8
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review7
Editorial introductions7
The role of surgery for locally advanced urothelial cancers7
Are robots the future? A case for robotic pyeloplasty as the gold standard treatment in ureteropelvic junction obstruction7
Liquid biomarkers in prostate cancer: recent advancements and future directions7
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
Quality indicators for the management of high-risk upper tract urothelial carcinoma requiring radical nephroureterectomy7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance7
Patient-reported outcomes in genital gender-affirming surgery7
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
Editorial introductions6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
Medical therapy for male infertility6
AI-powered radiomics: revolutionizing detection of urologic malignancies6
Health-related quality of life in bladder cancer patients: bladder cancer-specific instruments and domains. Part 26
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma6
Innovative systemic therapies for penile cancer6
Management of upper urinary tract problems after radical cystectomy for urothelial carcinoma: tips and tricks5
Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis5
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature5
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis5
Percutaneous management of caliceal diverticula: a narrative review5
Inflammation and kidney stones: cause and effect?5
Use of genomic markers to improve epidemiologic and clinical research in urology5
Advanced sperm tests and impact on clinical male factor management5
Implications and effects of COVID-19 on diagnosis and management of prostate cancer5
Surgical management of testicular cancer with limited retroperitoneal disease4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models4
Integration of novel artificial intelligence tools in pediatric urologic practice4
Editorial introductions4
Pelvic pain syndromes4
Role of cytoreductive surgery in the era of immunotherapy4
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses4
Editorial introductions4
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population4
Organ storage in renal transplantation4
Editorial: Future of kidney stone management4
Editorial introductions4
Robotic sacrocolpopexy in pelvic organ prolapse: a review of current literature4
Overlooked and underserved: how healthcare fails men in the pursuit of equity4
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers4
Genetics of testicular cancer: a review4
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era4
The use of MRI in urothelial carcinoma4
The environmental impacts of anesthesia4
New technologies for nephron-sparing surgery in upper urinary tract cancers4
Management of stage I testicular cancer4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis4
Metabolic evaluation: is there really a future?4
Update on the management of complex strictures of the bulbar urethra4
Preclinical models for bladder cancer therapy research4
0.11789178848267